Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG.

Source:http://linkedlifedata.com/resource/pubmed/id/16157621

Download in:

View as

General Info

PMID
16157621